Please Wait...

Upcoming Webinar: Outsourcing Pharmacovigilance: Pros and Cons and Lessons Learned

Join us for our upcoming webinar on July 25th during which Sukrit Singh and Dr. Ayesha Hussain, both pharmacovigilance experts who are also Associate Directors of CRM at Bioclinica, Inc., will present and discuss case studies illustrating how market authorization holders and CROs are becoming partners of choice in the ever-changing world of pharmacovigilance outsourcing.

The need to comply with regulatory requirements is increasing with the demand for new therapies across the pharmaceutical industry, which is seeking newer, more efficient ways of managing the growing load of adverse event data. Outsourcing is becoming a possible solution for short or long-term needs for more companies because of the:

  • Unavailability of the necessary system components for timely pharmacovigilance implementation by first-time marketing authorization holders.
  • Need for larger companies to streamline processes and reduce wastage, for a more robust and compliant reporting system.

The presented case studies will provide examples of:

  • Streamlining and globalizing processes to increase compliance rates with regulatory agencies.
  • Increasing productivity and reducing time to market.
  • Focusing on data quality.
  • Employing business excellence strategies to identify more effective ways of presenting accurate and meaningful data.
  • Employing tools that help market authorization holders achieve ease of operation and better transparency.

To join us for this webinar and learn more, register here.

Webinar: Outsourcing Pharmacovigilance: Pros and Cons and Lessons Learned

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

RT @bioclinica: Attending CBI's IRT conf? Catch 10/27 @bioclinica GSK talk on bens of sponsor controlled #IRT. Here's the core tech https:…
bioclinica (3 days ago)
RT @Xtalks: Clinical Event Adjudication: Comprehensive and Efficient Dossier Review Using a Global On-Line Solution @bioclinica https://t.c…
bioclinica (3 days ago)
RT @eClinical_Jen: Good Morning from NJ! @bioclinica is a sponsor of the clinical supply show because we have awesome supply forcasting and…
bioclinica (4 days ago)
Attending CBI's IRT conf? Catch 10/27 @bioclinica GSK talk on bens of sponsor controlled #IRT. Here's the core tech… https://t.co/zFiQswIQFb
bioclinica (5 days ago)
RT @Xtalks: #Cardiovascular Imaging for Monitoring Safety: Visualizing Outcomes @bioclinica https://t.co/5osqBkDFKm
bioclinica (5 days ago)
Want stellar imaging acquisition & assessment in your #clinicaltrial ? Get tips in @bioclinica 's Tim Crowe's blog https://t.co/hzbV3Cmlyc
bioclinica (6 days ago)

Latest Blogs: